Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-22 4:18 pm Purchase |
2023-12-20 | 13G | HOOKIPA Pharma Inc. HOOK |
GILEAD SCIENCES INC. GILD |
1,875,947 19.400% |
1,500,000 (+398.99%) |
Filing History |
| 2023-10-25 5:18 pm Purchase |
2023-10-16 | 13D | Assembly Biosciences, Inc. ASMB |
GILEAD SCIENCES INC. GILD |
1,089,472 19.900% |
1,089,472 (New Position) |
Filing History |
| 2023-10-19 3:33 pm Purchase |
2023-10-11 | 13G | Ikena Oncology, Inc. IKNA |
GILEAD SCIENCES INC. GILD |
2,931,467 6.700% |
2,931,467 (New Position) |
Filing History |
| 2023-07-06 09:38 am Purchase |
2023-06-28 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC. GILD |
25,586,953 35.000% |
2,863,797 (+12.60%) |
Filing History |
| 2023-02-14 2:06 pm Unchanged |
2022-03-24 | 13G | HOOKIPA Pharma Inc. HOOK |
GILEAD SCIENCES INC. GILD |
375,947 7.200% |
0 (Unchanged) |
Filing History |
| 2023-02-13 3:32 pm Sale |
2023-02-14 | 13G | Gilead Sciences, Inc. GILD |
Capital Research Global Investors | 54,602,952 4.400% |
-52,554,029 (-49.04%) |
Filing History |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | Gilead Sciences, Inc. GILD |
Capital World Investors | 68,900,998 5.500% |
12,538,508 (+22.25%) |
Filing History |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Gilead Sciences, Inc. GILD |
The Vanguard Group | 112,038,324 8.930% |
6,234,525 (+5.89%) |
Filing History |
| 2023-02-06 4:05 pm Purchase |
2023-01-26 | 13G | Arcellx, Inc. ACLX |
GILEAD SCIENCES INC. GILD |
3,478,261 7.300% |
3,478,261 (New Position) |
Filing History |
| 2023-01-31 08:55 am Purchase |
2022-12-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
131,555,769 10.500% |
4,623,076 (+3.64%) |
Filing History |
| 2022-08-05 5:52 pm Purchase |
2022-07-28 | 13G | AlloVir, Inc. ALVR |
GILEAD SCIENCES INC. GILD |
595,844 14.800% |
595,844 (New Position) |
Filing History |
| 2022-07-08 4:56 pm Purchase |
2022-06-30 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
126,932,693 10.100% |
7,971,487 (+6.70%) |
Filing History |
| 2022-02-17 2:43 pm Purchase |
2022-02-15 | 13G | HOOKIPA Pharma Inc. HOOK |
GILEAD SCIENCES INC. GILD |
375,947 12.900% |
166,667 (+79.64%) |
Filing History |
| 2022-02-17 2:11 pm Unchanged |
2021-12-31 | 13G | Agenus Inc. AGEN |
GILEAD SCIENCES INC. GILD |
566,111 4.300% |
0 (Unchanged) |
Filing History |
| 2022-02-11 12:22 pm Sale |
2022-02-14 | 13G | Gilead Sciences, Inc. GILD |
Capital Research Global Investors | 107,156,981 8.500% |
-14,515,418 (-11.93%) |
Filing History |
| 2022-02-10 4:55 pm Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
GILEAD SCIENCES INC. GILD |
1,450,566 9.200% |
377,266 (+35.15%) |
Filing History |
| 2022-02-10 4:51 pm Sale |
2021-04-20 | 13G | Allogene Therapeutics, Inc. ALLO |
GILEAD SCIENCES INC. GILD |
1,156,689 0.800% |
-6,330,000 (-84.55%) |
Filing History |
| 2022-02-10 4:50 pm Unchanged |
2021-12-31 | 13G | Agenus Inc. AGEN |
GILEAD SCIENCES INC. GILD |
566,111 4.300% |
0 (Unchanged) |
Filing History |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Gilead Sciences, Inc. GILD |
The Vanguard Group | 105,803,799 8.430% |
3,016,782 (+2.93%) |
Filing History |
| 2022-02-01 5:14 pm Purchase |
2021-12-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
118,961,206 9.500% |
7,777,872 (+7.00%) |
Filing History |